Skip to content
Open access · OA via OpenAlex

AAA-2016 CONFERENCE IDENTIFIES RAPALOG MILESTONE; NOMINATES EXEMPLARY HEALTHSPAN RESEARCH PROTOCOLS

R.J. Martin, Robert Ziman, W. Ashford, A. Wetherell, George M. Martin

Innovation in Aging · 2017

Abstract

Background: Research conferences generally cluster scientists by discipline and limit cross-disciplinary communication. Rushed presentations frequently truncate messages. Travel costs prevent most scientists from ever meeting one another. And delays prior to publication and [sometimes] year-long web-posting embargoes impede the progress we all desire. In some research areas preclinical and clinical trials have replication problems so severe that the US-National Institutes of Health funded a replication program which then failed to replicate 15 of 16 key studies [see PMIDs: 18838063,22078760,22134153,22177997]. Because the plenary discussion of the first large-scale healthspan(definition)/longevity trial, the TAME trial (Targeting/Taming Aging with MEtformin), was cut short by time constraints, a communication group formed to continue the healthspan-trial-design discussion after the American Aging Association conference (AAA-2016), thereby improving/speeding communication between conferees and with IAGG-2017 and other healthspan-related conferences. Methods: A brief 6-question survey (Healthspanstudy.com/Survey) invited trial-design recommendations, exemplary protocols, comments on memorable conference moments and research “milestones”. Results: TAME and rapalog milestones were supported by convincing (>3-to-1) majorities; blueberry-milestone by 1-to-1; exemplary trial protocols included the CALERIE Protocol [www.calerie.duke.edu/files/phase2_protocol.pdf specifically citing research samples now available], the US/NIH Toolbox[NIHToolbox.org], European AGARD STRES battery[www.ncbi.nlm.nih.gov/pubmed/9182033]; high-precision Memtrax.com-memory and Blueberry Study hearing websites. Main Conclusion: These results represent a rapalog-research milestone “[L]ife expectancy [increased] by more than 50%”[Kaeberlein]; “[R]apamycin can rejuvenate cardiac function, the cardiac proteome, metabolome and energetics”[Rabinovitch group]; RAD001 enhanced human immune-function and reduced impaired T-lymphocyte accumulation with age [Mannick]; “mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) reverses metabolic deficits in Lamin A/C-deficient mice”[Liao & Kennedy]; and reduces Aß accumulation and restores AD-like-memory deficits [Hussong & Galvan].

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/geroni/igx004.1427
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Martin, R., Ziman, R., Ashford, W., Wetherell, A., &amp; Martin, G.M. (2017). AAA-2016 CONFERENCE IDENTIFIES RAPALOG MILESTONE; NOMINATES EXEMPLARY HEALTHSPAN RESEARCH PROTOCOLS. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igx004.1427
Vancouver
Martin R, Ziman R, Ashford W, Wetherell A, Martin GM. AAA-2016 CONFERENCE IDENTIFIES RAPALOG MILESTONE; NOMINATES EXEMPLARY HEALTHSPAN RESEARCH PROTOCOLS. Innovation in Aging. 2017. doi:10.1093/geroni/igx004.1427.
BibTeX
@article{rj2017AAACON, title = {AAA-2016 CONFERENCE IDENTIFIES RAPALOG MILESTONE; NOMINATES EXEMPLARY HEALTHSPAN RESEARCH PROTOCOLS}, author = {R.J. Martin and Robert Ziman and W. Ashford and A. Wetherell and George M. Martin}, journal = {Innovation in Aging}, year = {2017}, doi = {10.1093/geroni/igx004.1427}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings